BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 19, Issue 8
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (6889)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-2) series.
Item 
Count 
PDF720
HTML5933
Figures (1-2)236
 Sum=6889
Feb 28, 2013 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Basaranoglu M, Basaranoglu G, Sentürk H. From fatty liver to fibrosis: A tale of “second hit”. World J Gastroenterol 2013; 19(8): 1158-1165 [PMID: 23483818 DOI: 10.3748/wjg.v19.i8.1158]
URL: https://www.wjgnet.com/1007-9327/full/v19/i8/1158.htm
Number Citing Articles
1
Pia S. Petersen, Xia Lei, Risa M. Wolf, Susana Rodriguez, Stefanie Y. Tan, Hannah C. Little, Michael A. Schweitzer, Thomas H. Magnuson, Kimberley E. Steele, G. William Wong. CTRP7 deletion attenuates obesity-linked glucose intolerance, adipose tissue inflammation, and hepatic stress. American Journal of Physiology-Endocrinology and Metabolism 2017; 312(4): E309 doi: 10.1152/ajpendo.00344.2016
2
Christophe Desterke, Franck Chiappini. Lipid Related Genes Altered in NASH Connect Inflammation in Liver Pathogenesis Progression to HCC: A Canonical Pathway. International Journal of Molecular Sciences 2019; 20(22): 5594 doi: 10.3390/ijms20225594
3
Long-Xin Qiu, Tong Chen. Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease. World Journal of Gastroenterology 2015; 21(4): 1099-1107 doi: 10.3748/wjg.v21.i4.1099
4
Kikuko Hotta, Takuya Kitamoto, Aya Kitamoto, Yuji Ogawa, Yasushi Honda, Takaomi Kessoku, Masato Yoneda, Kento Imajo, Wataru Tomeno, Satoru Saito, Atsushi Nakajima. Identification of the genomic region under epigenetic regulation during non‐alcoholic fatty liver disease progression. Hepatology Research 2018; 48(3) doi: 10.1111/hepr.12992
5
Toshio Nishi, Yuta Yamamoto, Naoko Yamagishi, Mikitaka Iguchi, Hideyuki Tamai, Takao Ito, Yoshihiro Tsuruo, Masao Ichinose, Masayuki Kitano, Takashi Ueyama. Lansoprazole prevents the progression of liver fibrosis in non-alcoholic steatohepatitis model rats. Journal of Pharmacy and Pharmacology 2018; 70(3): 383 doi: 10.1111/jphp.12870
6
Hermann-Georg Holzhütter, Nikolaus Berndt. Computational Hypothesis: How Intra-Hepatic Functional Heterogeneity May Influence the Cascading Progression of Free Fatty Acid-Induced Non-Alcoholic Fatty Liver Disease (NAFLD). Cells 2021; 10(3): 578 doi: 10.3390/cells10030578
7
Chunxue Yang, Lin Zhu, Qingzheng Kang, Hin Kiu Lee, Dapeng Li, Arthur C.K. Chung, Zongwei Cai. Chronic exposure to tetrabromodiphenyl ether (BDE-47) aggravates hepatic steatosis and liver fibrosis in diet-induced obese mice. Journal of Hazardous Materials 2019; 378: 120766 doi: 10.1016/j.jhazmat.2019.120766
8
Camila Sanches Manca, Lívia Maria Cordeiro Simões-Ambrosio, Paula Payão Ovídio, Leandra Zambelli Ramalho, Alceu Afonso Jordao, Chan‐Yen Kuo. Effects of Different Vegetable Oils on the Nonalcoholic Fatty Liver Disease in C57/BL Mice. Evidence-Based Complementary and Alternative Medicine 2023; 2023(1) doi: 10.1155/2023/4197955
9
Ju-Hwan Yang, Eun-Hye Byeon, Dawon Kang, Seong-Geun Hong, Jinsung Yang, Deok-Ryong Kim, Seung-Pil Yun, Sang-Won Park, Hyun-Joon Kim, Jae-Won Huh, So-Yong Kim, Young-Wan Kim, Dong-Kun Lee. Fermented Soybean Paste Attenuates Biogenic Amine-Induced Liver Damage in Obese Mice. Cells 2023; 12(5): 822 doi: 10.3390/cells12050822
10
Usama Abbasi, Srinivas Abbina, Arshdeep Gill, Lily E. Takuechi, Jayachandran N. Kizhakkedathu. Role of Iron in the Molecular Pathogenesis of Diseases and Therapeutic Opportunities. ACS Chemical Biology 2021; 16(6): 945 doi: 10.1021/acschembio.1c00122
11
Yiyuan Xi, Jujia Zheng, Wei Xie, Xiangwei Xu, Namki Cho, Xudong Zhou, Xiaomin Yu. (+)-Dehydrovomifoliol Alleviates Oleic Acid-Induced Lipid Accumulation in HepG2 Cells via the PPARα–FGF21 Pathway. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.750147
12
Colin T. Shearn, Kelly E. Mercer, David J. Orlicky, Leah Hennings, Rebecca L. Smathers-McCullough, Bangyan L. Stiles, Martin J. J. Ronis, Dennis R. Petersen, Michael Müller. Short Term Feeding of a High Fat Diet Exerts an Additive Effect on Hepatocellular Damage and Steatosis in Liver-Specific PTEN Knockout Mice. PLoS ONE 2014; 9(5): e96553 doi: 10.1371/journal.pone.0096553
13
Lingjuan Piao, Jiyeon Choi, Guideock Kwon, Hunjoo Ha. Endogenous catalase delays high-fat diet-induced liver injury in mice. The Korean Journal of Physiology & Pharmacology 2017; 21(3): 317 doi: 10.4196/kjpp.2017.21.3.317
14
J. Schragenheim, O. Maayan, N. G. Abraham. Gasotransmitters. 2018; : 59 doi: 10.1039/9781788013000-00059
15
Fengfeng Mo, Yuxiao Tang, Hui Shen, Lusha Wu, Qing Liu, Shuang Nie, Min Li, Chen Ling. HIF1α/miR-146α/TRAF6/NF-κB axis modulates hepatic iron overload-induced inflammation. The Journal of Nutritional Biochemistry 2024; 125: 109499 doi: 10.1016/j.jnutbio.2023.109499
16
Meiyu Jin, Haihua Feng, Yue Wang, Siru Yan, Bingyu Shen, Zheng Li, Haiyan Qin, Qi Wang, Jinxia Li, Guowen Liu. Gentiopicroside Ameliorates Oxidative Stress and Lipid Accumulation through Nuclear Factor Erythroid 2-Related Factor 2 Activation. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/2940746
17
Ai‐rong Zhang, Jing Sun, Yuan He, Ning Wang, Li Tian. Attenuation of lipid accumulation in Bel‐7402 cells through ADPN/AMPKα signaling stimulated by Fructus rosae laxae extract. Journal of Food Biochemistry 2020; 44(12) doi: 10.1111/jfbc.13497
18
Zhanwei Yang, Jing Zhao, Jing'en Li, Jin Wang, Wenjun Wang. Genome-wide DNA methylation profiling of high-fat emulsion-induced hyperlipidemia mice intervened by a polysaccharide from Cyclocarya paliurus (Batal) Iljinskaja. Food and Chemical Toxicology 2021; 152: 112230 doi: 10.1016/j.fct.2021.112230
19
Joost Willebrords, Bruno Cogliati, Isabel Veloso Alves Pereira, Tereza Cristina da Silva, Sara Crespo Yanguas, Michaël Maes, Veronica Mollica Govoni, Andressa Lima, Daniele Aparecida Felisbino, Elke Decrock, Marina Sayuri Nogueira, Inar Alves de Castro, Isabelle Leclercq, Luc Leybaert, Robim Marcelino Rodrigues, Mathieu Vinken. Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-08583-w
20
Xi Zhao, Jie Xue, Meilin Xie. Osthole inhibits oleic acid/lipopolysaccharide-induced lipid accumulation and inflammatory response through activating PPARα signaling pathway in cultured hepatocytes. Experimental Gerontology 2019; 119: 7 doi: 10.1016/j.exger.2019.01.014
21
S.M.B. Duarte, J.T. Stefano, L. Miele, F.R. Ponziani, M. Souza-Basqueira, L.S.R.R. Okada, F.G. de Barros Costa, K. Toda, D.F.C. Mazo, E.C. Sabino, F.J. Carrilho, A. Gasbarrini, C.P. Oliveira. Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study. Nutrition, Metabolism and Cardiovascular Diseases 2018; 28(4): 369 doi: 10.1016/j.numecd.2017.10.014
22
Mazhar A. Kanak, Yoshitaro Shindo, Pavithra SaiKumar, Bashoo Naziruddin. Inflammasomes: Clinical and Therapeutic Implications. Experientia Supplementum 2018; 108: 235 doi: 10.1007/978-3-319-89390-7_10
23
Hongguang Xia, Xiangyu Zhu, Xiaoyan Zhang, Haiyan Jiang, Biao Li, Zhihao Wang, Dalang Li, Yong Jin. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice. Biomedicine & Pharmacotherapy 2019; 118: 109287 doi: 10.1016/j.biopha.2019.109287
24
Xi Zhao, Feng Wang, Ruijun Zhou, Zengyan Zhu, Meilin Xie. PPARα/γ antagonists reverse the ameliorative effects of osthole on hepatic lipid metabolism and inflammatory response in steatohepatitic rats. Inflammopharmacology 2018; 26(2): 425 doi: 10.1007/s10787-017-0327-2
25
Luping Zhou, Lulu Chen, Xiangchang Zeng, Jianwei Liao, Dongsheng Ouyang. Ginsenoside compound K alleviates sodium valproate-induced hepatotoxicity in rats via antioxidant effect, regulation of peroxisome pathway and iron homeostasis. Toxicology and Applied Pharmacology 2020; 386: 114829 doi: 10.1016/j.taap.2019.114829
26
David Ipsen, Pernille Tveden-Nyborg, Jens Lykkesfeldt. Does Vitamin C Deficiency Promote Fatty Liver Disease Development?. Nutrients 2014; 6(12): 5473 doi: 10.3390/nu6125473
27
A. Drori, D. Rotnemer-Golinkin, S. Avni, A. Drori, O. Danay, D. Levanon, J. Tam, L. Zolotarev, Y. Ilan. Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0688-4
28
Tehila Daniel, Michaella Ben-Shachar, Elyashiv Drori, Sharleen Hamad, Anna Permyakova, Elad Ben-Cnaan, Joseph Tam, Zohar Kerem, Tovit Rosenzweig. Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice. The Journal of Nutritional Biochemistry 2021; 98: 108867 doi: 10.1016/j.jnutbio.2021.108867
29
F. Xia, L. Zeng, X.R. Yao, B.J. Zhou. Liver Pathophysiology. 2017; : 47 doi: 10.1016/B978-0-12-804274-8.00003-5
30
Bao Tung Pham, Wouter Tobias van Haaften, Dorenda Oosterhuis, Judith Nieken, Inge Anne Maria de Graaf, Peter Olinga. Precision-cut rat, mouse, and human intestinal slices as novel models for the early-onset of intestinal fibrosis. Physiological Reports 2015; 3(4): e12323 doi: 10.14814/phy2.12323
31
Zhongwen Feng, Lijun Pang, Siyun Chen, Xiaohong Pang, Yushen Huang, Qian Qiao, Yinglian Wang, Sayyaphone Vonglorkham, Quanfang Huang, Xing Lin, Jinbin Wei. Didymin ameliorates dexamethasone-induced non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB and PI3K/Akt pathways in C57BL/6J mice. International Immunopharmacology 2020; 88: 107003 doi: 10.1016/j.intimp.2020.107003
32
Meagan Rose, Martin Veysey, Mark Lucock, Suzanne Niblett, Katrina King, Surinder Baines, Manohar L. Garg. Association between erythrocyte omega-3 polyunsaturated fatty acid levels and fatty liver index in older people is sex dependent. Journal of Nutrition & Intermediary Metabolism 2016; 5: 78 doi: 10.1016/j.jnim.2016.04.007
33
Ning Wang, Xiajing Li, Zhiyong Zhong, Yaqi Qiu, Shoupei Liu, Haibin Wu, Xianglian Tang, Chuxin Chen, Yingjie Fu, Qicong Chen, Tingting Guo, Jinsong Li, Shuai Zhang, Mark A. Zern, Keqiang Ma, Bailin Wang, Yimeng Ou, Weili Gu, Jie Cao, Honglin Chen, Yuyou Duan. 3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFβRII-SMADS pathway. Journal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-01138-2
34
Nina Graffmann, Sarah Ring, Marie-Ann Kawala, Wasco Wruck, Audrey Ncube, Hans-Ingo Trompeter, James Adjaye. Modeling Nonalcoholic Fatty Liver Disease with Human Pluripotent Stem Cell-Derived Immature Hepatocyte-Like Cells Reveals Activation of PLIN2 and Confirms Regulatory Functions of Peroxisome Proliferator-Activated Receptor Alpha. Stem Cells and Development 2016; 25(15): 1119 doi: 10.1089/scd.2015.0383
35
Christopher Leung, Leni Rivera, John B. Furness, Peter W. Angus. The role of the gut microbiota in NAFLD. Nature Reviews Gastroenterology & Hepatology 2016; 13(7): 412 doi: 10.1038/nrgastro.2016.85
36
Huifang Gao, Yaru Cao, Hongguang Xia, Xiangyu Zhu, Yong Jin. CYP4A11 is involved in the development of nonalcoholic fatty liver disease via ROS‑induced lipid peroxidation and inflammation . International Journal of Molecular Medicine 2020;  doi: 10.3892/ijmm.2020.4479
37
Sandra Milic, Ivana Mikolasevic, Lidija Orlic, Edita Devcic, Nada Starcevic-Cizmarevic, Davor Stimac, Miljenko Kapovic, Smiljana Ristic. The Role of Iron and Iron Overload in Chronic Liver Disease. Medical Science Monitor 2016; 22: 2144 doi: 10.12659/MSM.896494
38
Cynthia L. Vuittonet, Michael Halse, Lorenzo Leggio, Samuel B. Fricchione, Michael Brickley, Carolina L. Haass-Koffler, Tonya Tavares, Robert M. Swift, George A. Kenna. Pharmacotherapy for alcoholic patients with alcoholic liver disease. American Journal of Health-System Pharmacy 2014; 71(15): 1265 doi: 10.2146/ajhp140028
39
Sanja Stojsavljević, Marija Gomerčić Palčić, Lucija Virović Jukić, Lea Smirčić Duvnjak, Marko Duvnjak. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(48): 18070-18091 doi: 10.3748/wjg.v20.i48.18070
40
Rustu Turkay, Abdurrahman Fatih Aydin, Ilknur Bingul, Canan Kucukgergin, Isin Dogan-Ekici, Elif Hocaoglu, Ercan Inci, Baris Bakir, Mujdat Uysal. Can Ultrasound Imaging Predict the Success of an Experimental Steatofibrosis Model?. Ultrasound Quarterly 2017; 33(2): 157 doi: 10.1097/RUQ.0000000000000286
41
Colin T. Shearn, Laura M. Saba, James R. Roede, David J. Orlicky, Alisabeth H. Shearn, Dennis R. Petersen. Differential carbonylation of proteins in end-stage human fatty and nonfatty NASH. Free Radical Biology and Medicine 2017; 113: 280 doi: 10.1016/j.freeradbiomed.2017.10.004
42
Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Eugeniusz Tarasów, Małgorzata Wojtkowska, Irena Białokoz-Kalinowska, Dariusz Marek Lebensztejn. Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/3870454
43
Jelte J. Schaapman, Maarten E. Tushuizen, Minneke J. Coenraad, Hildo J. Lamb. Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease. Journal of Magnetic Resonance Imaging 2021; 53(6): 1623 doi: 10.1002/jmri.27292
44
Flavia A Cimini, Ilaria Barchetta, Simone Carotti, Laura Bertoccini, Marco G Baroni, Umberto Vespasiani-Gentilucci, Maria-Gisella Cavallo, Sergio Morini. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(19): 3407-3417 doi: 10.3748/wjg.v23.i19.3407
45
Wanpeng Lu, Jinyu Mei, Juan Yang, Zhihan Wu, Jiayuan Liu, Pengyu Miao, Yiliang Chen, Zhenfan Wen, Zhongting Zhao, Hua Kong, Chao Wu, Yan Yang, Ming Chen. ApoE deficiency promotes non-alcoholic fatty liver disease in mice via impeding AMPK/mTOR mediated autophagy. Life Sciences 2020; 252: 117601 doi: 10.1016/j.lfs.2020.117601
46
Terry D. Hinds, Komal Sodhi, Charles Meadows, Larisa Fedorova, Nitin Puri, Dong Hyun Kim, Stephen J. Peterson, Joseph Shapiro, Nader G. Abraham, Attallah Kappas. Retracted: Increased HO‐1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21. Obesity 2014; 22(3): 705 doi: 10.1002/oby.20559
47
Metin Basaranoglu, Alev Kurtoglu. Replacing the Name of NAFLD With a Metabolic or Another Forename as Indicator of the Era of Stagnation in NASH Studies. Journal of Clinical Gastroenterology 2021; 55(6): 548 doi: 10.1097/MCG.0000000000001494
48
Elham Nazari, Ghazaleh Khalili-Tanha, Alireza Asadnia, Ghazaleh Pourali, Mina Maftooh, Majid Khazaei, Mohammadreza Nasiri, Seyed Mahdi Hassanian, Majid Ghayour-Mobarhan, Gordon A. Ferns, Mohammad Ali Kiani, Amir Avan. Bioinformatics analysis and machine learning approach applied to the identification of novel key genes involved in non-alcoholic fatty liver disease. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-46711-x
49
Mahyar Mohammadifard, Zeinab Saremi, Mahboobe Rastgoo, Ehsan Akbari. Relevance between Helicobacter pylori Infection and Non-Alcoholic Fatty Liver Disease in Birjand, Iran. Journal of Medicine and Life 2019; 12(2): 168 doi: 10.25122/jml-2019-0012
50
Taynã Cristina Tiburcio, Joost Willebrords, Tereza Cristina da Silva, Isabel Veloso Alves Pereira, Marina Sayuri Nogueira, Sara Crespo Yanguas, Michaël Maes, Elisangela dos Anjos Silva, Maria Lucia Zaidan Dagli, Inar Alves de Castro, Cláudia Pinto Oliveira, Mathieu Vinken, Bruno Cogliati. Connexin32 deficiency is associated with liver injury, inflammation and oxidative stress in experimental non‐alcoholic steatohepatitis. Clinical and Experimental Pharmacology and Physiology 2017; 44(2): 197 doi: 10.1111/1440-1681.12701
51
Shenghu Zhu, Linshu Guan, Xuemei Tan, Guoquan Li, Changjie Sun, Meng Gao, Bao Zhang, Lina Xu. Hepatoprotective Effect and Molecular Mechanisms of Hengshun Aromatic Vinegar on Non-Alcoholic Fatty Liver Disease. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.585582
52
Katharina Brandl, Bernd Schnabl. The Human Microbiota and Chronic Disease. 2016; : 339 doi: 10.1002/9781118982907.ch22
53
Dennis R. Petersen, Laura M. Saba, Volkan I. Sayin, Thales Papagiannakopoulos, Edward E. Schmidt, Gary F. Merrill, David J. Orlicky, Colin T. Shearn, Manlio Vinciguerra. Elevated Nrf-2 responses are insufficient to mitigate protein carbonylation in hepatospecific PTEN deletion mice. PLOS ONE 2018; 13(5): e0198139 doi: 10.1371/journal.pone.0198139
54
Irene Besné-Eseverri, María Ángeles Martín, Gloria Lobo, M. Pilar Cano, María P. Portillo, Jenifer Trepiana. Antioxidant and Anti-Inflammatory Effects of Opuntia Extracts on a Model of Diet-Induced Steatosis. Antioxidants 2024; 13(11): 1416 doi: 10.3390/antiox13111416
55
Yiyi Jin, Zhaoshui Shangguan, Jiao Pang, Yuwen Chen, Suijin Lin, Hekun Liu. Pin1 Exacerbates Non-Alcoholic Fatty Liver Disease by Enhancing Its Activity through Binding to ACC1. International Journal of Molecular Sciences 2024; 25(11): 5822 doi: 10.3390/ijms25115822
56
Neveen Rashad Mostafa, Abeer A.M. Ali, Mona Gamalludin Alkaphoury, Roy Rillera Marzo. <i>Helicobacter Pylori</i> infection and non-alcoholic fatty liver disease. Is there a relationship?. Healthcare in Low-resource Settings 2023; 11(1) doi: 10.4081/hls.2023.11379
57
Atsuo Tahara, Toshiyuki Takasu. Therapeutic Effects of SGLT2 Inhibitor Ipragliflozin and Metformin on NASH in Type 2 Diabetic Mice. Endocrine Research 2020; 45(2): 147 doi: 10.1080/07435800.2020.1713802
58
G Teixeira, C Szyndralewiez, S Molango, S Carnesecchi, F Heitz, P Wiesel, J M Wood. Therapeutic potential of NADPH oxidase 1/4 inhibitors. British Journal of Pharmacology 2017; 174(12): 1647 doi: 10.1111/bph.13532
59
Iala Milene Bertasso, Carla Bruna Pietrobon, Rosane Aparecida Ribeiro, Gabriela Moreira Soares, Janaina Chaves de Oliveira, Ana Claudia Paiva Alegre-Maller, Antonio Carlos Boschero, Allan Cezar Faria Araújo, Ana Tereza Bittencourt Guimarães, Maria Lúcia Bonfleur, Sandra Lucinei Balbo. Pregnancy and lactation after Roux-en-Y gastric bypass worsen nonalcoholic fatty liver disease in obese rats and lead to differential programming of hepatic de novo lipogenesis in offspring. Journal of Developmental Origins of Health and Disease 2022; 13(2): 263 doi: 10.1017/S2040174421000271
60
Xin Chu, Qunyan Jin, Hui Chen, G. Craig Wood, Anthony Petrick, William Strodel, Jon Gabrielsen, Peter Benotti, Tooraj Mirshahi, David J. Carey, Christopher D. Still, Johanna K. DiStefano, Glenn S. Gerhard. CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading. Journal of Translational Medicine 2018; 16(1) doi: 10.1186/s12967-018-1490-y
61
Ying-Chun Wang, Wei-Zong Kong, Qing-Mei Jin, Juan Chen, Lei Dong. Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis. World Journal of Gastroenterology 2015; 21(35): 10104-10112 doi: 10.3748/wjg.v21.i35.10104
62
Metin Basaranoglu. Lean and Nonobese NAFLD/NASH From a Hepatologist’s Point of View. Journal of Clinical Gastroenterology 2021; 55(1): 93 doi: 10.1097/MCG.0000000000001428
63
Pooja Yadav, Khushi Quadri, Renu Kadian, Aafrin Waziri, Pankaj Agrawal, Md Sabir Alam. New Approaches to the Treatment of Metabolic Dysfunction-Associated Steatotic Liver with Natural Products. iLIVER 2024; : 100131 doi: 10.1016/j.iliver.2024.100131
64
Christopher R. Day, Stephen A. Kempson. Betaine chemistry, roles, and potential use in liver disease. Biochimica et Biophysica Acta (BBA) - General Subjects 2016; 1860(6): 1098 doi: 10.1016/j.bbagen.2016.02.001
65
Yushuang Wei, Mengzhu Zhao, Fang Yang, Yang Mao, Hang Xie, Qibing Zhou. Iron overload by Superparamagnetic Iron Oxide Nanoparticles is a High Risk Factor in Cirrhosis by a Systems Toxicology Assessment. Scientific Reports 2016; 6(1) doi: 10.1038/srep29110
66
Gang Cheng, Arun P. Palanisamy, Zachary P. Evans, Alton G. Sutter, Lan Jin, Inderjit Singh, Harold May, Michael G. Schmidt, Kenneth D. Chavin, Rajesh Mohanraj. Cerulenin Blockade of Fatty Acid Synthase Reverses Hepatic Steatosis in ob/ob Mice. PLoS ONE 2013; 8(9): e75980 doi: 10.1371/journal.pone.0075980
67
Engy A. Aboulwafa, Doaa M. Shawky, Ahmed Farag Seddik. A Transfer Learning Approach for the Automatic Detection of Fatty Liver from Ultrasound Images. 2021 11th International Conference on Advanced Computer Information Technologies (ACIT) 2021; : 726 doi: 10.1109/ACIT52158.2021.9548566
68
Fang‐tian Bu, Ao Wang, Yan Zhu, Hong‐mei You, Ya‐fei Zhang, Xiao‐ming Meng, Cheng Huang, Jun Li. LncRNANEAT1: Shedding light on mechanisms and opportunities in liver diseases. Liver International 2020; 40(11): 2612 doi: 10.1111/liv.14629
69
Giuseppe Della Pepa, Claudia Vetrani, Gianluca Lombardi, Lutgarda Bozzetto, Giovanni Annuzzi, Angela Rivellese. Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals. Nutrients 2017; 9(10): 1065 doi: 10.3390/nu9101065
70
Sławomir Dariusz Szajda, Jacek Dobryniewski, Alina Minarowska, Jadwiga Snarska, Napoleon Waszkiewicz, Krzysztof Zwierz. The Effect of Neoglandin on the Activity of N-Acetyl-β-D-Hexosaminidase in the Serum and Urine of Alcohol-Dependent Men. International Journal of Environmental Research and Public Health 2023; 20(4): 3413 doi: 10.3390/ijerph20043413
71
Ryan E. Feaver, Banumathi K. Cole, Mark J. Lawson, Stephen A. Hoang, Svetlana Marukian, Brett R. Blackman, Robert A. Figler, Arun J. Sanyal, Brian R. Wamhoff, Ajit Dash. Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis. JCI Insight 2016; 1(20) doi: 10.1172/jci.insight.90954
72
Seren Ozenirler, Gulbanu Erkan, Ceyla Konca Degertekin, Ugur Ercin, Mustafa Cengiz, Ayse Bilgihan, Guldal Yilmaz, Gulen Akyol. The relationship between advanced oxidation protein products (AOPP) and biochemical and histopathological findings in patients with nonalcoholic steatohepatitis. Journal of Digestive Diseases 2014; 15(3): 131 doi: 10.1111/1751-2980.12113
73
Javier López-Prieto, Emilio González-Reimers, M. Remedios Alemán-Valls, María José de la Vega-Prieto, Pedro Abreu-González, Ricardo Pelazas-González, Rubén Hernández-Luis, Carlos Jorge-Ripper, Francisco Santolaria-Fernández. Iron and Proinflammatory Cytokines in Chronic Hepatitis C Virus Infection. Biological Trace Element Research 2013; 155(1): 5 doi: 10.1007/s12011-013-9760-2
74
Metin Basaranoglu, Sonia M Najjar, Ali Ebag Demirbag, Hakan Senturk. Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list. World Journal of Hepatology 2016; 8(7): 376-384 doi: 10.4254/wjh.v8.i7.376
75
Ya-yun Liu, Jiao-jiao You, Wei Xu, Ting Zhai, Chun-yuan Du, Yong Chen, Feng-mei Han. Gynura procumbens aqueous extract alleviates nonalcoholic steatohepatitis through CFLAR-JNK pathway in vivo and in vitro. Chinese Herbal Medicines 2019; 11(4): 369 doi: 10.1016/j.chmed.2019.09.005
76
Chuang Zhu, Qi Guan, Chenwei Song, Lingyue Zhong, Xinwen Ding, Hui Zeng, Pan Nie, Lihua Song. Regulatory effects of Lactobacillus fermented black barley on intestinal microbiota of NAFLD rats. Food Research International 2021; 147: 110467 doi: 10.1016/j.foodres.2021.110467
77
Kaiyue Wang, Wangxiao Tan, Xiao Liu, Lina Deng, Lu Huang, Xiaoying Wang, Xiumei Gao. New insight and potential therapy for NAFLD: CYP2E1 and flavonoids. Biomedicine & Pharmacotherapy 2021; 137: 111326 doi: 10.1016/j.biopha.2021.111326
78
M. O. Chyzh, I. V. Koshurba, M. M. Marchenko, F. V. Hladkykh, I. V. Belochkina. Gender determinism of the effect of placenta cryoextract on the hepatotropic effects of esomeprazole, clarithromycin and metronidazole in chronic liver damage. Modern medical technology 2023; (1): 55 doi: 10.34287/MMT.1(56).2023.9
79
Liyun Wang, Kahua Liu, Liang Deng, Guanyu Zhou, Wei Qian, Keshu Xu. Exploration of Perturbed Liver Fibrosis-Related Factors and Collagen Type I in Animal Model of Non-Alcoholic Fatty Liver Disease. Applied Biochemistry and Biotechnology 2024; 196(6): 3260 doi: 10.1007/s12010-023-04694-5
80
Ziyang Li, Chaoliang Xiong, Suo Mo, Haiying Tian, Mengqian Yu, Tingting Mao, Qian Chen, Haitao Luo, Quanzhen Li, Jianxin Lu, Yi Zhao, Wei Li, Yu Xue. Comprehensive Transcriptome Analyses of the Fructose-Fed Syrian Golden Hamster Liver Provides Novel Insights into Lipid Metabolism. PLOS ONE 2016; 11(9): e0162402 doi: 10.1371/journal.pone.0162402
81
E. Chávez, M. Galicia-Moreno, P. Muriel. Liver Pathophysiology. 2017; : 729 doi: 10.1016/B978-0-12-804274-8.00052-7
82
Sizhao Lu, Robert G Bennett, Kusum K Kharbanda, Duygu Dee Harrison-Findik. Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver. World Journal of Hepatology 2016; 8(4): 211-225 doi: 10.4254/wjh.v8.i4.211
83
Azza S. M. Awad, Ekram N. Abd Al Haleem, Wesam M. El-Bakly, Mohie A. Sherief. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. Naunyn-Schmiedeberg's Archives of Pharmacology 2016; 389(4): 381 doi: 10.1007/s00210-015-1207-1
84
Monika Zajkowska, Barbara Mroczko. Chemokines in Primary Liver Cancer. International Journal of Molecular Sciences 2022; 23(16): 8846 doi: 10.3390/ijms23168846
85
Ting Zhai, Wei Xu, Yayun Liu, Kun Qian, Yanling Xiong, Yong Chen, Tullia Maraldi. Honokiol Alleviates Methionine-Choline Deficient Diet-Induced Hepatic Steatosis and Oxidative Stress in C57BL/6 Mice by Regulating CFLAR-JNK Pathway. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/2313641
86
Nina Graffmann, Lucas-Sebastian Spitzhorn, Audrey Ncube, Wasco Wruck, James Adjaye. Essential Current Concepts in Stem Cell Biology. Learning Materials in Biosciences 2020; : 189 doi: 10.1007/978-3-030-33923-4_11
87
Chongli Xu, Yu Liu, Yuchen Gong, Xinping Duan, Xiaochun Tang, Mingjun Zhang, Daxin Pang, Liqing Yu, Hong Wei, Hongsheng Ouyang. Overexpression of NPC1L1 in the livers of transgenic Bama miniature pigs accelerates lipid peroxidation. Genes & Genomics 2015; 37(2): 183 doi: 10.1007/s13258-014-0235-4
88
Lijia Zhang, Xuezheng Dai, Li Wang, Jingming Cai, Jie Shen, Yang Shen, Xianan Li, Yan Zhao. Iron overload accelerated lipid metabolism disorder and liver injury in rats with non-alcoholic fatty liver disease. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.961892
89
María José Monedero-Prieto, José María González-Pérez, Emilio González-Reimers, Onán Hernández-Pérez, María Monereo-Muñoz, Luis Galindo-Martín, Geraldine Quintero-Platt, Pedro Abreu-González. Effects of Selenium on Liver and Muscle Contents and Urinary Excretion of Zinc, Copper, Iron and Manganese. Biological Trace Element Research 2014; 158(2): 224 doi: 10.1007/s12011-014-9928-4
90
Noha A. El-Boghdady, Maher A. Kamel, Rouaina M. El-Shamy. Omeprazole and Spirulina Platensis Ameliorate Steatohepatitis in Experimental Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Disorders 2020; 18(9): 426 doi: 10.1089/met.2019.0129
91
Masuko Kobori, Yinhua Ni, Yumiko Takahashi, Natsumi Watanabe, Minoru Sugiura, Kazunori Ogawa, Mayumi Nagashimada, Shuichi Kaneko, Shigehiro Naito, Tsuguhito Ota, Marcia B. Aguila. β-Cryptoxanthin Alleviates Diet-Induced Nonalcoholic Steatohepatitis by Suppressing Inflammatory Gene Expression in Mice. PLoS ONE 2014; 9(5): e98294 doi: 10.1371/journal.pone.0098294
92
Atul Goyale, Anjly Jain, Colette Smith, Margarita Papatheodoridi, Marta Guerrero Misas, Davide Roccarina, Laura Iogna Prat, Dimitri P. Mikhailidis, Devaki Nair, Emmanuel Tsochatzis, Pavel Strnad. Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study. PLOS ONE 2021; 16(11): e0260313 doi: 10.1371/journal.pone.0260313
93
Hilmar K L&uuml;ckhoff, Frederik C Kruger, Maritha J Kotze. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries. World Journal of Hepatology 2015; 7(9): 1192-1208 doi: 10.4254/wjh.v7.i9.1192
94
Thing-Fong Tzeng, Yu-Cheng Tzeng, Yu-Jou Cheng, Shorong-Shii Liou, I-Min Liu. The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model. Nutrients 2015; 7(10): 8670 doi: 10.3390/nu7105423
95
Sevda Tanrıkulu-Küçük, Canan Başaran-Küçükgergin, Muhammed Seyithanoğlu, Semra Doğru-Abbasoğlu, Hikmet Koçak, Şule Beyhan-Özdaş, Yıldız Öner-İyidoğan. Effect of dietary curcumin and capsaicin on testicular and hepatic oxidant–antioxidant status in rats fed a high-fat diet. Applied Physiology, Nutrition, and Metabolism 2019; 44(7): 774 doi: 10.1139/apnm-2018-0622
96
Ayala Wollman, Tehila Daniel, Tovit Rosenzweig. Sarcopoterium spinosum Inhibited the Development of Non-Alcoholic Steatosis and Steatohepatitis in Mice. Nutrients 2019; 11(12): 3044 doi: 10.3390/nu11123044
97
Colin T. Shearn, Blair Fennimore, David J. Orlicky, Yue R. Gao, Laura M. Saba, Kayla D. Battista, Stefanos Aivazidis, Mohammed Assiri, Peter S. Harris, Cole Michel, Gary F. Merrill, Edward E. Schmidt, Sean P. Colgan, Dennis R. Petersen. Cholestatic liver disease results increased production of reactive aldehydes and an atypical periportal hepatic antioxidant response. Free Radical Biology and Medicine 2019; 143: 101 doi: 10.1016/j.freeradbiomed.2019.07.036
98
Yayun Liu, Qingqing Yu, Yong Chen. Effect of silibinin on CFLAR-JNK pathway in oleic acid-treated HepG2 cells. Biomedicine & Pharmacotherapy 2018; 108: 716 doi: 10.1016/j.biopha.2018.09.089
99
Zhuhuang Zhou, Jui Fang, Anca Cristea, Ying-Hsiu Lin, Yu-Wei Tsai, Yung-Liang Wan, Kee-Min Yeow, Ming-Chih Ho, Po-Hsiang Tsui. Value of homodyned K distribution in ultrasound parametric imaging of hepatic steatosis: An animal study. Ultrasonics 2020; 101: 106001 doi: 10.1016/j.ultras.2019.106001
100
Liyuan Hao, Shenghao Li, Guo Chen, Xiaoyu Hu. Regulation of UCP2 in nonalcoholic fatty liver disease: From mechanisms to natural product. Chemical Biology & Drug Design 2024; 103(2) doi: 10.1111/cbdd.14461
101
Yoojin Lee, Ji-Young Lee. Dietary Interventions in Liver Disease. 2019; : 91 doi: 10.1016/B978-0-12-814466-4.00008-2
102
Si-Si Jin, Xian-Fan Lin, Ju-Zeng Zheng, Qiong Wang, Hua-Qin Guan. lncRNA NEAT1 regulates fibrosis and inflammatory response induced by nonalcoholic fatty liver by regulating miR-506/GLI3. European Cytokine Network 2019; 30(3): 98 doi: 10.1684/ecn.2019.0432
103
Byoung-Joon Song, Mohammed Akbar, Mohamed A. Abdelmegeed, Kyunghee Byun, Bonghee Lee, Seung Kew Yoon, James P. Hardwick. Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications. Redox Biology 2014; 3: 109 doi: 10.1016/j.redox.2014.10.004
104
E. Ramos-Tovar, P. Muriel. Liver Pathophysiology. 2017; : 743 doi: 10.1016/B978-0-12-804274-8.00053-9
105
Valéria Nunes-Souza, Cheila Juliana César-Gomes, Lucas José Sá Da Fonseca, Glaucevane Da Silva Guedes, Salete Smaniotto, Luíza Antas Rabelo, Vladimir Jakovljevic. Aging Increases Susceptibility to High Fat Diet‐Induced Metabolic Syndrome in C57BL/6 Mice: Improvement in Glycemic and Lipid Profile after Antioxidant Therapy. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/1987960
106
Zeping Huang, Jian Zheng, Jie Zeng, Xiaoli Wang, Tao Wu, Rongqin Zheng. Normal Liver Stiffness in Healthy Adults Assessed By Real-Time Shear Wave Elastography and Factors That Influence This Method. Ultrasound in Medicine & Biology 2014; 40(11): 2549 doi: 10.1016/j.ultrasmedbio.2014.05.008
107
Fan Xia, Xiaorui Yao, Waijiao Tang, Chunxin Xiao, Miaoting Yang, Benjie Zhou. Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte Injury. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00099
108
Giuseppina Palladini, Laura G. Di Pasqua, Clarissa Berardo, Veronica Siciliano, Plinio Richelmi, Stefano Perlini, Andrea Ferrigno, Mariapia Vairetti. Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress. Canadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/5413461
109
Meiqi Fan, Young-Jin Choi, Yujiao Tang, Sung Mun Bae, Hyun Pil Yang, Eun-Kyung Kim. Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease. Nutrients 2019; 11(11): 2586 doi: 10.3390/nu11112586
110
Sharmin Akter. Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology. Middle East Journal of Digestive Diseases 2022; 14(2): 167 doi: 10.34172/mejdd.2022.270
111
Thing-Fong Tzeng, Shorong-Shii Liou, I.-Min Liu. 6-Gingerol mitigates nutritional steatohepatitis through regulating key genes related to oxidative stress, inflammation and fibrogenesis. RSC Adv. 2014; 4(106): 61427 doi: 10.1039/C4RA12030B
112
Hong Xu, Gao-Feng Chen, Yu-Shui Ma, Hong-Wei Zhang, Yang Zhou, Guang-Hui Liu, Dong-Ya Chen, Jian Ping, Yi-Hui Liu, Xin Mou, Da Fu. Hepatic Proteomic Changes and Sirt1/AMPK Signaling Activation by Oxymatrine Treatment in Rats With Non-alcoholic Steatosis. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00216
113
Martin J. J. Ronis, Kelly E. Mercer, Brenda Gannon, Bridgette Engi, Piotr Zimniak, Colin T. Shearn, David J. Orlicky, Emanuele Albano, Thomas M. Badger, Dennis R. Petersen. Increased 4-hydroxynonenal protein adducts in male GSTA4–4/PPAR-α double knockout mice enhance injury during early stages of alcoholic liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2015; 308(5): G403 doi: 10.1152/ajpgi.00154.2014
114
Deise Jaqueline Ströher, Micaela Federizzi de Oliveira, Patrícia Martinez-Oliveira, Bruna Cocco Pilar, Márcia Denise Pavanelo Cattelan, Eliseu Rodrigues, Kalyne Bertolin, Paulo Bayard Dias Gonçalves, Jacqueline da Costa Escobar Piccoli, Vanusa Manfredini. Virgin Coconut Oil Associated with High-Fat Diet Induces Metabolic Dysfunctions, Adipose Inflammation, and Hepatic Lipid Accumulation. Journal of Medicinal Food 2020; 23(7): 689 doi: 10.1089/jmf.2019.0172
115
Shuqin Wang, Xue Li, Weizhe Xu, Jing Gao, Yin Wang, Xiaoyuan Jia, Gongchu Li, Qiuwei Pan, Kan Chen. Amelioration of Hepatic Steatosis by the Androgen Receptor Inhibitor EPI-001 in Mice and Human Hepatic Cells Is Associated with the Inhibition of CYP2E1. International Journal of Molecular Sciences 2022; 23(24): 16063 doi: 10.3390/ijms232416063
116
Hanlin Shi, Xiaohong Duan, Jingcheng Dong, Yanyan Tao, Yang Lei. RNA-seq combined network pharmacology reveals that Fu-Gan-Wan (FGW) inhibits liver fibrosis via NF-κB/CCL2/CCR2 and lipid peroxidation via Nrf2/HMOX1 signaling pathway. Journal of Ethnopharmacology 2024; 326: 117963 doi: 10.1016/j.jep.2024.117963
117
Xiaorui Yao, Fan Xia, Waijiao Tang, Chunxin Xiao, Miaoting Yang, Benjie Zhou. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats. Journal of Ethnopharmacology 2018; 212: 208 doi: 10.1016/j.jep.2017.09.016
118
Azam Moslehi, Tahereh Komeili-Movahed. The Effects of Rosmarinic Acid on the Liver Fibrosis Induced by Non-alcoholic Steatohepatitis in Male Mice. Qom Univ Med Sci J 2021; 15(1): 2 doi: 10.52547/qums.15.1.2
119
Rasha A. Al-Shali, Wafaa S. Ramadan. Germinated barley downregulates hepatic stearoyl-CoA desaturase-1 enzyme gene expression in a hepatic steatohepatitis rat model. Anatomical Science International 2020; 95(4): 489 doi: 10.1007/s12565-020-00546-y
120
Felix F. Schmidt, Dajana Lichtenstein, Hannes Planatscher, Almut Mentz, Joern Kalinowski, Andreas E. Steinhilber, Thomas O. Joos, Albert Braeuning, Oliver Pötz. Pesticide mixture effects on liver protein abundance in HepaRG cells. Toxicology 2021; 458: 152839 doi: 10.1016/j.tox.2021.152839
121
Yoshitaka Kondo, Hirofumi Masutomi, Yoshihiro Noda, Yusuke Ozawa, Keita Takahashi, Setsuko Handa, Naoki Maruyama, Takahiko Shimizu, Akihito Ishigami. Senescence marker protein‐30/superoxide dismutase 1 double knockout mice exhibit increased oxidative stress and hepatic steatosis. FEBS Open Bio 2014; 4(1): 522 doi: 10.1016/j.fob.2014.05.003
122
Daniel Leclerc, Karen E. Christensen, Alaina M. Reagan, Vafa Keser, Yan Luan, Olga V. Malysheva, Brandi Wasek, Teodoro Bottiglieri, Marie A. Caudill, Gareth R. Howell, Rima Rozen. Folate Deficiency and/or the Genetic Variant Mthfr677C >T Can Drive Hepatic Fibrosis or Steatosis in Mice, in a Sex‐Specific Manner. Molecular Nutrition & Food Research 2024; 68(5) doi: 10.1002/mnfr.202300355
123
Roberto Catanzaro, Federica Calabrese, Sergio Occhipinti, Maria Grazia Anzalone, Angelo Italia, Michele Milazzo, Francesco Marotta. Nonalcoholic Fatty Liver Disease Increases Risk for Gastroesophageal Reflux Symptoms. Digestive Diseases and Sciences 2014; 59(8): 1939 doi: 10.1007/s10620-014-3113-7
124
Yangyue Ni, Mengwen Huang, Shiyang Chen, Shihui Wang, Jianfeng Chen. Integrins and NAFLD-associated liver diseases: clinical associations, pathophysiological mechanisms and pharmacological implications. Acta Biochimica et Biophysica Sinica 2024;  doi: 10.3724/abbs.2024149
125
Xiangyu Guo, Xunzhe Yin, Zuojia Liu, Jin Wang. Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. International Journal of Molecular Sciences 2022; 23(24): 15489 doi: 10.3390/ijms232415489
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345